Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks.

Holmes T, Yan F, Ko KH, Nordon R, Song E, O'Brien TA, Dolnikov A.

Cell Prolif. 2012 Jun;45(3):266-78. doi: 10.1111/j.1365-2184.2012.00813.x. Epub 2012 Mar 20.

PMID:
22429797
2.

Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

Guenechea G, Segovia JC, Albella B, Lamana M, Ramírez M, Regidor C, Fernández MN, Bueren JA.

Blood. 1999 Feb 1;93(3):1097-105.

3.

Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.

McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E.

Exp Hematol. 2002 Jun;30(6):612-6.

PMID:
12063029
4.

Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.

Fei XM, Wu YJ, Chang Z, Miao KR, Tang YH, Zhou XY, Wang LX, Pan QQ, Wang CY.

Cytotherapy. 2007;9(4):338-47.

PMID:
17573609
5.

In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.

Exp Hematol. 2000 Dec;28(12):1470-80.

PMID:
11146169
6.

The plant lectin FRIL supports prolonged in vitro maintenance of quiescent human cord blood CD34(+)CD38(-/low)/SCID repopulating stem cells.

Kollet O, Moore JG, Aviram R, Ben-Hur H, Liu BL, Nagler A, Shultz L, Feldman M, Lapidot T.

Exp Hematol. 2000 Jun;28(6):726-36.

PMID:
10880759
7.

Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.

Albella B, Segovia JC, Guenechea G, Pragnell IB, Bueren JA.

Transplantation. 1999 May 27;67(10):1348-57.

PMID:
10360589
8.

Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.

Ong LM, Fan X, Chu PP, Gay FP, Bari S, Ang JM, Li Z, Chen J, Lim SK, Bunte RM, Hwang WY.

Biol Blood Marrow Transplant. 2012 May;18(5):674-82. doi: 10.1016/j.bbmt.2012.01.001. Epub 2012 Jan 9.

9.

In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells.

Denning-Kendall PA, Evely R, Singha S, Chapman M, Bradley BA, Hows JM.

Br J Haematol. 2002 Jan;116(1):218-28.

PMID:
11841420
10.

Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.

Piacibello W, Sanavio F, Severino A, Danè A, Gammaitoni L, Fagioli F, Perissinotto E, Cavalloni G, Kollet O, Lapidot T, Aglietta M.

Blood. 1999 Jun 1;93(11):3736-49.

11.

Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.

Huang GP, Pan ZJ, Jia BB, Zheng Q, Xie CG, Gu JH, McNiece IK, Wang JF.

Cell Transplant. 2007;16(6):579-85.

PMID:
17912949
12.

Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.

Rossmanith T, Schröder B, Bug G, Müller P, Klenner T, Knaus R, Hoelzer D, Ottmann OG.

Stem Cells. 2001;19(4):313-20.

13.
14.

Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity.

Wyrsch A, dalle Carbonare V, Jansen W, Chklovskaia E, Nissen C, Surbek D, Holzgreve W, Tichelli A, Wodnar-Filipowicz A.

Exp Hematol. 1999 Aug;27(8):1338-45.

PMID:
10428511
15.

Increased expansion and differentiation of cord blood products using a two-step expansion culture.

McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S.

Exp Hematol. 2000 Oct;28(10):1181-6.

PMID:
11027837
16.

Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.

Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.

Exp Hematol. 2008 Feb;36(2):244-52. Epub 2007 Nov 26.

PMID:
18023520
17.

Hematopoietic capability of CD34+ cord blood cells: a comparison with CD34+ adult bone marrow cells.

Ueda T, Yoshida M, Yoshino H, Kobayashi K, Kawahata M, Ebihara Y, Ito M, Asano S, Nakahata T, Tsuji K.

Int J Hematol. 2001 Jun;73(4):457-62.

PMID:
11503959
18.

Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.

Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, Casper RF, Zandstra PW.

Biol Blood Marrow Transplant. 2006 Oct;12(10):1020-30.

19.
20.

Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.

Foguenne J, Di Stefano I, Giet O, Beguin Y, Gothot A.

Haematologica. 2009 Feb;94(2):185-94. doi: 10.3324/haematol.13206. Epub 2009 Jan 14.

Supplemental Content

Support Center